The FDA Jan. 21 approved Horizon Therapeutics' drug, Tepezza, the first drug designed to treat thyroid eye disease.
Thyroid eye disease is a rare disease where muscles and fatty tissues behind the eyes become inflamed and cause the eyes to push forward and bulge outward. It can cause eye pain, double vision, light sensitivity or difficulty closing the eye.
The disease affects more women than men and can be incapacitating, preventing people from driving or working.
Tepezza is the first drug to be approved by the FDA to treat thyroid eye disease.
Read the full article here.